ImetelChat

For whatever it's worth, 49 of the 50 "Oncology Key Account Manager" positions have been taken down. The only one left standing is out of Jackson, MS. https://workforcenow.adp.com/mascsr/default/mdf/recruitment/recruitment.html?cid=a69f1432-af4c-471b-88c8-44c7c81587aa&ccId=19000101_000001&type=JS&la...

Probably one of the best digs in a very long time. Thank you Wildrides over on YMB! I agree Ryan that the anonymous letter from the MDS patient in Leipzig is quite impressive: "......since December 2021 I have been transfusion-free with very good blood values. This is a remarkable improvement in my ...

Since Janssen funded 50% of both P2 CTs, I would imagine Janssen spent $150-$300M if not more over the course of 4yrs. -Kmall https://ir.geron.com/investors/press-releases/press-release-details/2014/Geron-Announces-Global-Strategic-Collaboration-with-Janssen--to-Develop-and-Commercialize-Imetelstat/...

This $2B+ figure, will certainly factor into any BO or partnership considerations. -Kmall

"Bristol Myers (BMY) has a partnership with Merck (NYSE:MRK) to jointly advance and promote Reblozyl after the latter company acquired its original developer, Acceleron Pharma, in November 2021. The treatment is already indicated in the EU as a late-line option for adults with anemia due to MDS. If ...

LWS - I'm sorry, but this isn't the forum for politics. Period. What I posted was directly tied to the inactions of the FDA. That is a topic of discussion here. You need to take your views to a more appropriate outlet. While I can respect anyone's thought process or decision, it doesn't mean that I ...

LWS - I don't think politics belong on this forum. The ONLY reason that I even posted on the plight of the horseshoe crab was that it was tied to the beaurocratic policies of the FDA. Because of this it faces extinction. The FDA is a topical discussion here as it effects the outcome of Imetelstat's ...

143 signatures added to the petition in the last week..... pretty impressive, considering this was started in July 2020.....but we can do better. This should be in the tens of thousands, if not millions......we're talking about SEVERAL species teetering on the verge of extinction, particularly due t...

Ryan - understood, but the data is the data....it's superior to any other BAT, and they had 8+ months to review before making that decision. New molecular drugs have been approved in the past to serve an unmet need. It certainly appears to be a case of more than meets the eye in the approval hurdles...

Ridiculous that the FDA didn't set priority review here. Hundreds, if not thousands of patients will needlessly die while they dragged this out an additional 10 months......what the hell does Fast Track Designation imply? -Kmall

Jayfish - drug and link? TIA -Kmall

And Bp - thanks for your support of the blue blooded mollusk, which encompasses a much greater spectrum of species.....BTW - they are considered to be in the scorpion/spider family rather than mollusks.....a little food for thought. -Kmall

Bp - just a small correction to your post, Geron does have over a half dozen UK based employees headed by Sharon McBain - Head of Global Regulatory. -Kmall

Ryan - you know that's the next shoe to drop in this never ending saga of delays......Oy Vey !!!! -Kmall

LWS and all others who have taken the time to sign this petition.....THANK YOU!!!!

125 signatures added since Wednesday.....not too shabby. -Kmall

LWS - you sign the petition yet? -Kmall

They are all options granted. No one "purchased" anything. Box 5 reads 5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5) All Form 4's have box 5 Options granted have an exp. date in 2034 Acquired doesn't mean they put up $$$ for them....they are acquired. You're ...

Persang - Thanks to you and possibly another 100+ readers of Imetelchat, the petition drive posted here has added 120 signatures since Wednesday!! Thank you to all who have taken the opportunity to do so. I fully understand that Imetelchat's focus isn't necessarily the horseshoe crab. And quite fran...